Hyperglycemia in-hospital management

Therapeutic Advances in Endocrinology and Metabolism

Volumn 2, Issue 1, 2011, Pages 3-7

  Prieto Sanchez, Luz Marina ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE;

BLOOD GLUCOSE MONITORING; BRAIN DAMAGE; CLINICAL COMPETENCE; CLINICAL PROTOCOL; DIABETES MELLITUS; DIET THERAPY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEART ARRHYTHMIA; HOSPITAL CARE; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; MEDICAL EDUCATION; MICROANGIOPATHY; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK REDUCTION; SEIZURE;

EID: 79960049850     PISSN: 20420188     EISSN: 20420196     Source Type: Journal    
DOI: 10.1177/2042018810397083     Document Type: Editorial

References (24)

1. American Diabetes Association. (2011) Standards of medical care. Diabetes Care 34 supplement 1; S11–S61.
2. Azuma K. et al (2003) A new en face method is useful to quantitate endothelial damage in vivo. Biochem Byophys Res Commun 309: 384–390.
3. Ceriello A. Ihnat M. (2010) “Glycaemic variability”: a new therapeutic challenge in diabetes and the critical care setting. Diabetes Med 27: 862–867.
4. Clement S. Braithwaite S.S. Magee M.F. Ahmann A. Smith E.P. Schafer R.G. et al (2004) Management of diabetes and hyperglycemia in Hospitals. Diabetes Care 27: 553–591.
5. Dotson S. Freeman R. Failing H.J. Adler G.K. (2008) Hypoglycemia increases serum IL-6 levels in healthy men and women. Diabetes Care 31: 1222–1223.
6. Finfer S. et al (2009) NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360: 1283–1297.
7. Furnary A.P. et al (2003) Continuous intravenous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125: 1007–1021.
8. Keller-Wood M.E. et al (1983) Inhibition of the adreno-corticotropin and corticoid responses in hypoglycemia after prior stress. Endocrinology 113: 491–496.
9. Kilpatrick E.S. Rigby A.S. Atkin S.L. (2010) Glucose variability and diabetes complication risk: we need to know the answer. Diabetic Med 27: 868–871.
10. Knecht L.A. Gauthier S.M. Castro J.C. Schmidt R.E. Whitaker M.D. Zimmerman R.S. et al (2006) Diabetes care in the hospital: is there clinical inertia? J Hosp Med 1: 151–160.
11. Levetan C.S. et al (1998) Unrecognized diabetes among hospitalized patients. Diabetes Care 21: 246–249.
12. Magee M. (2007) Hospital protocols for targeted glycemic control: Development, implementation and models for cost justification. Am J Health-Syst Pharm 64(Suppl. 6): S15–S20.
13. Matheny M.E. et al (2008) Treatment intensification and blood glucose control among hospitalized diabetic patients. J Gen Inter Med 23: 184–189.
14. Moghissi, E.S., Korytkowski, M.T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I.B. et al (2009) AACE and ADA consensus statement on inpatient glycemic control. Diabetes Care 32; 1119–1131.
15. Monnier L. Colette C. Owens D.R. (2009) Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept. Diabetes Metab Res Rev 25: 393–402.
16. Monnier L. et al (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295: 1681–1687.
17. Newton C.A. Young S. (2006) Financial implications of glycemic control: results of an inpatient diabetes management program. Endocrine Practice 12(Suppl. 3): 43–48.
18. Piconi L. Quagliaro L. Assaloni R. Da Ros R. Maier A. Zuodar G. et al (2006) Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction. Diabetes Metab Res Rev 22: 198–203.
19. Service F.J. Molnar G.D. Rosevear J.W. Ackerman E. Gatewood L.C. Taylor W.F. (1970) Mean amplitude of glycemic excursions, a measure of diabetes instability. Diabetes 19: 644–655.
20. Siegelar S. Holleman F. Hoekstra J.B. DeVries J.H. (2010) Glucose variability; Does it matter? Endocrine Rev 31: 171–182.
21. Sung J. et al (2005) Admission hyperglycemia is predictive of outcomes in critically ill trauma patients. J Trauma 59: 80–83.
22. Umpierrez G.E. et al (2002) Hyperglycemia: an independent marker of in-hospital mortality in patient with undiagnosed diabetes. J Clin Endocrinol Metab 87: 978–982.
23. Umpierrez G.E. Smiley D. Jacobs S. Peng L. Temponi A. Mulligan P. et al (2007) Randomized study of basal-bolus insulin therapy in the in-patient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care 30: 2181–2186.
24. van den Berghe G. Wouters P. Weekers F. Verwaest C. Bruyninckx F. Schetz M. et al (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345: 1359–1367.